Share
CBS News
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
By Khristopher J. Brooks | 5 Nov 2020
RELATED TOPICS:
North Korean Leader Says Past Diplomacy Only Confirmed US Hostility
12 hours ago
Democrats Strike Deal to Get More Biden Judges Confirmed Before Congress Adjourns
12 hours ago
Average Rate on a 30-Year Mortgage in the US Rises to Highest Level Since July
14 hours ago
Cutting in Line? American Airlines’ New Boarding Tech Might Stop You at Now Over 100 Airports
14 hours ago
MLB Will Test Robot Umpires at 13 Spring Training Ballparks Hosting 19 Teams
15 hours ago
$165 Billion Revenue Error Continues to Haunt California’s Budget